Basics C4 Therapeutics, Inc. IPO Date: October 2, 2020 Sector: Healthcare Industry: Biotech Market Cap: $193.58M Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 3.93% Avg Daily Range (30 D): $0.10 | 4.24% Avg Daily Range (90 D): $0.09 | 4.96% Institutional Daily Volume Avg Daily Volume: 1.34M Avg Daily Volume (30 D): 1.3M Avg Daily Volume (90 D): 1.15M Trade Size Avg Trade Size (Sh.): 137 Avg Trade Size (Sh.) (30 D): 187 Avg Trade Size (Sh.) (90 D): 178 Institutional Trades Total Inst.Trades: 1,037 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $1.74M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.19M Avg Closing Trade (30 D): $7.13M Avg Closing Trade (90 D): $4.05M Avg Closing Volume: 186.32K     News May 7, 2025 @ 11:00 AM C4 Therapeutics Reports First Quarter 2025 Financi... Source: C4 Therapeutics Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight Jan 9, 2025 @ 3:53 PM NUT Midline Carcinoma Treatment Market Research Re... Source: Researchandmarkets.Com Dec 8, 2024 @ 5:30 PM C4 Therapeutics Presents Cemsidomide Phase 1 Data ... Source: N/A Nov 20, 2024 @ 12:00 PM C4 Therapeutics Appoints Accomplished Oncology Exe... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.37 $-.37 Diluted EPS $-.37 $-.37 Revenue $ $ 6.46M $ 7.24M Gross Profit $ $ $ Net Income / Loss $ $ -26.02M $ -26.32M Operating Income / Loss $ $ -28.5M $ -29.16M Cost of Revenue $ $ $ Net Cash Flow $ $ 26.86M $ -4.21M PE Ratio